Merrimack Pharmaceuticals Inc MACK:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
4.69UNCH (UNCH)
Volume
160
Close
4.69quote price arrow up+0.16 (+3.53%)
Volume
14,728
52 week range
3.56 - 9.45
Loading...
  • Open4.53
  • Day High4.82
  • Day Low4.53
  • Prev Close4.53
  • 52 Week High9.45
  • 52 Week High Date02/11/21
  • 52 Week Low3.56
  • 52 Week Low Date11/12/20

Key Stats

  • Market Cap62.89M
  • Shares Out13.41M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta2.21
  • YTD % Change-31.93

KEY STATS

  • Open4.53
  • Day High4.82
  • Day Low4.53
  • Prev Close4.53
  • 52 Week High9.45
  • 52 Week High Date02/11/21
  • 52 Week Low3.56
  • 52 Week Low Date11/12/20
  • Market Cap62.89M
  • Shares Out13.41M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta2.21
  • YTD % Change-31.93

RATIOS/PROFITABILITY

  • EPS (TTM)-0.27
  • P/E (TTM)-17.59
  • Fwd P/E (NTM)-1.46
  • EBITDA (TTM)-3.317M
  • ROE (TTM)-22.01%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)94.58%
  • Net Margin (TTM)-159.70%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date12/13/2019
  • Div Amount0.50
  • Split Date-
  • Split Factor-

Latest On Merrimack Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is entitled to receive contingent milestone payments related to its sale of ONIVYDE to Ipsen S.A. ONIVYDE is approved by the Unites States Food and Drug Administration (FDA) in combination with fluorouracil (5-FU) and leucovorin (LV) for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy. The Company does not have any...
Gary Crocker
Chairman
Address
1 Broadway Fl 14
Cambridge, MA
02142-1187
United States

Top Peers

SYMBOLLASTCHG%CHG
GLMD
Galmed Pharmaceuticals Ltd
2.77+0.07+2.59%
OGEN
Oragenics Inc
0.59-0.0097-1.6175%
SLNO
Soleno Therapeutics Inc
0.7942-0.0068-0.8489%
NDRA
ENDRA Life Sciences Inc
1.70+0.07+4.29%
IMRA
Imara Inc
3.63-0.09-2.42%
AKTX
Akari Therapeutics PLC
1.73+0.03+1.87%